Biosimilar G-CSF (filgrastim) is also efficient for peripheral blood stem cell mobilisation and no cryopreserved autologous transplantation

被引：0
|
作者：
Yafour, N. [1 ]
Osmani, S. [1 ]
Talhi, S. [1 ]
Brahimi, M. [1 ]
Hebbar, A. [1 ]
Bekadja, S. [1 ]
Mehalli, S. [1 ]
Benmir, I. [1 ]
Arabi, A. [1 ]
Bouhass, R. [1 ]
Bekadja, M. A. [1 ]
机构：
[1] Univ Oran, Oran, DZ, Algeria
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S243 / S243
页数：1
相关论文
共 50 条
  • [41] The use of granulocyte colony stimulating factor (G-CSF) (filgrastim) alone in the mobilization of stem cells in autologous stem cell transplantation
    Osmani, S.
    Talhi, S.
    Brahimi, M.
    Yafour, N.
    Attaf, F.
    Bouhass, R.
    Arabi, A.
    Bekadja, M. -A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S182 - S182
  • [42] The role of G-CSF administration on+5th day after autologous peripheral blood stem cell transplantation
    Basköy, K
    Arpaci, F
    Ozet, A
    Komucu, S
    Ozturk, B
    Beyzadeoglu, M
    Sengul, A
    Yalcin, A
    BONE MARROW TRANSPLANTATION, 2003, 31 : S106 - S106
  • [43] Telomere length predicts neutrophil recovery in the absence of G-CSF after autologous peripheral blood stem cell transplantation
    Lincz, LF
    Scorgie, FE
    Sakoff, JA
    Fagan, KA
    Ackland, SP
    Enno, A
    BONE MARROW TRANSPLANTATION, 2004, 34 (05) : 439 - 445
  • [44] Telomere length predicts neutrophil recovery in the absence of G-CSF after autologous peripheral blood stem cell transplantation
    L F Lincz
    F E Scorgie
    J A Sakoff
    K A Fagan
    S P Ackland
    A Enno
    Bone Marrow Transplantation, 2004, 34 : 439 - 445
  • [45] USE OF A BIOSIMILAR GRANULOCYTE COLONY STIMULATING FACTOR (GCSF) FOR PERIPHERAL BLOOD STEM CELL MOBILISATION PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION: AN ANALYSIS OF MOBILISATION AND ENGRAFTMENT
    Publicover, F.
    Richardson, D.
    Hill, K.
    Jenner, M.
    Davies, A.
    Lamb, J.
    Hutchins, D.
    Launders, H.
    Orchard, K.
    HAEMATOLOGICA, 2012, 97 : 182 - 182
  • [46] Use of the G-CSF Biosimilar Ratiograstim® to Mobilize Peripheral Stem Cells in Healthy Donors for Allogeneic Stem Cell Transplantation
    Schmitt, Michael
    Lena, Diestel
    Schneider, Catarina
    Xu, Xun
    Borchert, Kersten
    Glaeser, Dietrich
    Hilgendorf, Inken
    Scheuerlein, Robert
    Freund, Mathias
    Schmitt, Anita
    BLOOD, 2011, 118 (21) : 840 - 840
  • [47] Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF
    M Offidani
    L Corvatta
    A Olivieri
    S Rupoli
    J Frayfer
    A Mele
    E Manso
    M Montanari
    R Centurioni
    P Leoni
    Bone Marrow Transplantation, 1999, 24 : 1079 - 1087
  • [48] Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF
    Offidani, M
    Corvatta, L
    Olivieri, A
    Rupoli, S
    Frayfer, J
    Mele, A
    Manso, E
    Montanari, M
    Centurioni, R
    Leoni, P
    BONE MARROW TRANSPLANTATION, 1999, 24 (10) : 1079 - 1087
  • [49] G-CSF (filgrastim) administered in addition to interferon alpha (IF) to mobilize peripheral blood stem cells (PBSC) for autologous transplantation in chronic myeloid leukemia (CML).
    Archimbaud, E
    Michallet, M
    Philip, L
    Charrin, C
    Clapisson, G
    Belhabri, A
    Guilhot, F
    Stryckmans, P
    Adeleine, P
    Fiere, D
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 494 - 494
  • [50] Delayed administration of filgrastim (G-CSF) following autologous peripheral blood stem cell transplant (APBSCT) in pediatric patients does not change time to neutrophil engraftment and reduces use of G-CSF
    Pai, Vinita
    Fernandez, Soledad
    Laudick, Melissa
    Rosselet, Robin
    Termuhlen, Amanda
    PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 620 - 620
12345